Groundbreaking stem-cell research boosts Marlborough-based ACT

Widely reported research published Tuesday in the medical journal, The Lancet, spells good news for a Marlborough company that less than two months ago executed a 100-for-1 reverse stock split to dig itself out of penny stock territory.

http://ift.tt/1vw6Ui2